Overview of the Current Challenges in Pulmonary Coccidioidomycosis

Coccidioidomycosis is a disease caused by soil fungi of the genus <i>Coccidioides</i>, divided genetically into <i>Coccidioides immitis</i> (California isolates) and <i>Coccidioides posadasii</i> (isolates outside California). Coccidioidomycosis is transmitted thr...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohamed A. Fayed, Timothy M. Evans, Eyad Almasri, Kathryn L. Bilello, Robert Libke, Michael W. Peterson
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Journal of Fungi
Subjects:
Online Access:https://www.mdpi.com/2309-608X/10/10/724
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850206197607563264
author Mohamed A. Fayed
Timothy M. Evans
Eyad Almasri
Kathryn L. Bilello
Robert Libke
Michael W. Peterson
author_facet Mohamed A. Fayed
Timothy M. Evans
Eyad Almasri
Kathryn L. Bilello
Robert Libke
Michael W. Peterson
author_sort Mohamed A. Fayed
collection DOAJ
description Coccidioidomycosis is a disease caused by soil fungi of the genus <i>Coccidioides</i>, divided genetically into <i>Coccidioides immitis</i> (California isolates) and <i>Coccidioides posadasii</i> (isolates outside California). Coccidioidomycosis is transmitted through the inhalation of fungal spores, arthroconidia, which can cause disease in susceptible mammalian hosts, including humans. Coccidioidomycosis is endemic to the western part of the United States of America, including the central valley of California, Arizona, New Mexico, and parts of western Texas. Cases have been reported in other regions in different states, and endemic pockets are present in these states. The incidence of reported cases of coccidioidomycosis has notably increased since it became reportable in 1995. Clinically, the infection ranges from asymptomatic to fatal disease due to pneumonia or disseminated states. The recognition of coccidioidomycosis can be challenging, as it frequently mimics bacterial community-acquired pneumonia. The diagnosis of coccidioidomycosis is frequently dependent on serologic testing, the results of which can take several days or longer to obtain. Coccidioidomycosis continues to present challenges for clinicians, and suspected cases can be easily missed. The challenges of coccidioidomycosis disease, from presentation to diagnosis to treatment, remain a hurdle for clinicians, and further research is needed to address these challenges.
format Article
id doaj-art-28bbeb613f2d4477b28ba8cea95d7475
institution OA Journals
issn 2309-608X
language English
publishDate 2024-10-01
publisher MDPI AG
record_format Article
series Journal of Fungi
spelling doaj-art-28bbeb613f2d4477b28ba8cea95d74752025-08-20T02:10:54ZengMDPI AGJournal of Fungi2309-608X2024-10-01101072410.3390/jof10100724Overview of the Current Challenges in Pulmonary CoccidioidomycosisMohamed A. Fayed0Timothy M. Evans1Eyad Almasri2Kathryn L. Bilello3Robert Libke4Michael W. Peterson5Pulmonary Critical Care Division, University of California San Francisco, Fresno Campus, Fresno, CA 93701, USAPulmonary Critical Care Division, University of California San Francisco, Fresno Campus, Fresno, CA 93701, USAPulmonary Critical Care Division, University of California San Francisco, Fresno Campus, Fresno, CA 93701, USAPulmonary Critical Care Division, University of California San Francisco, Fresno Campus, Fresno, CA 93701, USAInfectious Disease Division, University of California San Francisco, Fresno Campus, Fresno, CA 93701, USAPulmonary Critical Care Division, University of California San Francisco, Fresno Campus, Fresno, CA 93701, USACoccidioidomycosis is a disease caused by soil fungi of the genus <i>Coccidioides</i>, divided genetically into <i>Coccidioides immitis</i> (California isolates) and <i>Coccidioides posadasii</i> (isolates outside California). Coccidioidomycosis is transmitted through the inhalation of fungal spores, arthroconidia, which can cause disease in susceptible mammalian hosts, including humans. Coccidioidomycosis is endemic to the western part of the United States of America, including the central valley of California, Arizona, New Mexico, and parts of western Texas. Cases have been reported in other regions in different states, and endemic pockets are present in these states. The incidence of reported cases of coccidioidomycosis has notably increased since it became reportable in 1995. Clinically, the infection ranges from asymptomatic to fatal disease due to pneumonia or disseminated states. The recognition of coccidioidomycosis can be challenging, as it frequently mimics bacterial community-acquired pneumonia. The diagnosis of coccidioidomycosis is frequently dependent on serologic testing, the results of which can take several days or longer to obtain. Coccidioidomycosis continues to present challenges for clinicians, and suspected cases can be easily missed. The challenges of coccidioidomycosis disease, from presentation to diagnosis to treatment, remain a hurdle for clinicians, and further research is needed to address these challenges.https://www.mdpi.com/2309-608X/10/10/724coccidioidomycosisvalley feverpulmonary noduleslung masspyopneumothorax
spellingShingle Mohamed A. Fayed
Timothy M. Evans
Eyad Almasri
Kathryn L. Bilello
Robert Libke
Michael W. Peterson
Overview of the Current Challenges in Pulmonary Coccidioidomycosis
Journal of Fungi
coccidioidomycosis
valley fever
pulmonary nodules
lung mass
pyopneumothorax
title Overview of the Current Challenges in Pulmonary Coccidioidomycosis
title_full Overview of the Current Challenges in Pulmonary Coccidioidomycosis
title_fullStr Overview of the Current Challenges in Pulmonary Coccidioidomycosis
title_full_unstemmed Overview of the Current Challenges in Pulmonary Coccidioidomycosis
title_short Overview of the Current Challenges in Pulmonary Coccidioidomycosis
title_sort overview of the current challenges in pulmonary coccidioidomycosis
topic coccidioidomycosis
valley fever
pulmonary nodules
lung mass
pyopneumothorax
url https://www.mdpi.com/2309-608X/10/10/724
work_keys_str_mv AT mohamedafayed overviewofthecurrentchallengesinpulmonarycoccidioidomycosis
AT timothymevans overviewofthecurrentchallengesinpulmonarycoccidioidomycosis
AT eyadalmasri overviewofthecurrentchallengesinpulmonarycoccidioidomycosis
AT kathrynlbilello overviewofthecurrentchallengesinpulmonarycoccidioidomycosis
AT robertlibke overviewofthecurrentchallengesinpulmonarycoccidioidomycosis
AT michaelwpeterson overviewofthecurrentchallengesinpulmonarycoccidioidomycosis